1. Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell. 2004. 6:463–477.
2. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene. 2004. 23:2891–2906.
3. Schwarze PE, Seglen PO. Reduced autophagic activity, improved protein balance and enhanced in vitro survival of hepatocytes isolated from carcinogen-treated rats. Exp Cell Res. 1985. 157:15–28.
4. Canuto RA, Tessitore L, Muzio G, Autelli R, Baccino FM. Tissue protein turnover during liver carcinogenesis. Carcinogenesis. 1993. 14:2581–2587.
5. Kisen GO, Tessitore L, Costelli P, Gordon PB, Schwarze PE, Baccino FM, et al. Reduced autophagic activity in primary rat hepatocellular carcinoma and ascites hepatoma cells. Carcinogenesis. 1993. 14:2501–2505.
6. Ahlberg J, Yucel T, Eriksson L, Glaumann H. Characterization of the proteolytic compartment in rat hepatocyte nodules. Virchows Arch B Cell Pathol Incl Mol Pathol. 1987. 53:79–88.
7. Yucel T, Ahlberg J, Glaumann H. Overall proteolysis in perfused and subfractionated chemically induced malignant hepatoma of rat: effects of amino acids. Exp Mol Pathol. 1989. 50:38–49.
8. Levine B. Cell biology: autophagy and cancer. Nature. 2007. 446:745–747.
9. Bursch W, Ellinger A, Kienzl H, Török L, Pandey S, Sikorska M, et al. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis. 1996. 17:1595–1607.
10. Kanzawa T, Kondo Y, Ito H, Kondo S, Germano I. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res. 2003. 63:2103–2108.
11. Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E, et al. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 2001. 61:439–444.
12. Yao KC, Komata T, Kondo Y, Kanzawa T, Kondo S, Germano IM. Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy. J Neurosurg. 2003. 98:378–384.
13. Butler R, Mitchell SH, Tindall DJ, Young CY. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2. Cell Growth Differ. 2000. 11:49–61.
14. Fram RJ. Cisplatin and platinum analogues: recent advances. Curr Opin Oncol. 1992. 4:1073–1079.
15. Karantza-Wadsworth V, White E. Role of autophagy in breast cancer. Autophagy. 2007. 3:610–613.
16. Levine B. Unraveling the role of autophagy in cancer. Autophagy. 2006. 2:65–66.
17. Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC, et al. Anti- and pro-tumor functions of autophagy. Biochim Biophys Acta. 2009. 1793:1524–1532.
18. Levine B, Abrams J. p53: the Janus of autophagy? Nat Cell Biol. 2008. 10:637–639.
19. Høyer-Hansen M, Jäättelä M. Autophagy: an emerging target for cancer therapy. Autophagy. 2008. 4:574–580.
20. Jin S, White E. Role of autophagy in cancer: management of metabolic stress. Autophagy. 2007. 3:28–31.
21. Maiuri MC, Tasdemir E, Criollo A, Morselli E, Vicencio JM, Carnuccio R, et al. Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ. 2009. 16:87–93.
22. Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ. Potential therapeutic applications of autophagy. Nat Rev Drug Discov. 2007. 6:304–312.